KENTERA

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug KENTERA contains one active pharmaceutical ingredient (API):

1	Oxybutinin UNII K9P6MC7092 - OXYBUTYNIN
	Oxybutynin acts as a competitive antagonist of acetylcholine at post-ganglionic muscarinic receptors, resulting in relaxation of bladder smooth muscle.
	Read more about Oxybutinin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KENTERA Transdermal patch	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BD04	Oxybutynin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1199044, 1199055, 1199066, 1538478, 1538489
ES	Centro de información online de medicamentos de la AEMPS	03270001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	019306, 019543, 019571
FR	Base de données publique des médicaments	66488746
GB	Medicines & Healthcare Products Regulatory Agency	379905, 381436
IE	Health Products Regulatory Authority	21456, 30274, 30276
IT	Agenzia del Farmaco	038812018, 038812020, 038812032, 038812044, 038812057
LT	Valstybinė vaistų kontrolės tarnyba	1028885, 1028886, 1028887, 1063126, 1063127
NL	Z-Index G-Standaard, PRK	78581
PL	Rejestru Produktów Leczniczych	100296380, 100311139
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51531001, W51531002, W51531003
TR	İlaç ve Tıbbi Cihaz Kurumu	8699559810011